Belantamab Mafodotin-blmf Chemical Structure (Blenrep Spl Graphic 01)
Not available.*
Blenrep Injection, Powder, For Solution
Product Images NDC 0173-0913
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Blenrep (NDC 0173-0913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glaxosmithkline Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Blenrep Spl Graphic 02)
Figure 2 (Blenrep Spl Graphic 03)
Blenrep 70 mg Per Vial Carton (Blenrep Spl Graphic 04)
This text provides information about a medication called BLENREP (belantamab mafodotin-blmf) for injection, which is administered through intravenous infusion after reconstitution and dilution. It is important to note that this drug is hazardous and contains no preservative. Each package includes a single-dose vial, and any unused portion should be discarded. Additionally, it is necessary to dispense the enclosed Medication Guide to each patient. The National Drug Code (NDC) for this medication is 0173-0913-01.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
